Skip to main content

Dawes Karen A's Form 4 filing

Repligen Corp (RGEN) · filed Nov 4, 2021

Accession no.
0000899243-21-043038
Filed
Nov 4, 2021
Trade date
Nov 2, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions and 0 derivative transactions. Open-market sales total $729.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Dawes Karen ACIK 0001261506Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 2, 2021Common StockSSaleDisposed−64$299.02−$19,137.2893,583Direct
Nov 2, 2021Common StockSSaleDisposed−251$301.20−$75,601.293,332Direct
Nov 2, 2021Common StockSSaleDisposed−446$301.97−$134,678.6292,886Direct
Nov 2, 2021Common StockSSaleDisposed−532$303.48−$161,451.3692,354Direct
Nov 2, 2021Common StockSSaleDisposed−124$304.23−$37,724.5292,230Direct
Nov 2, 2021Common StockSSaleDisposed−700$305.91−$214,13791,530Direct
Nov 2, 2021Common StockSSaleDisposed−283$306.49−$86,736.6791,247Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)